Verification method of implantable detection device, implantable detection device, device and electronic equipment
By outputting square wave signals and generating calibration curves to calibrate the detection device, the detection error problems caused by changes in sensitivity and performance differences in blood glucose detection sensors during long-term use are solved, and detection accuracy and stability are improved.
Patent Information
- Application Number
- CN202411446018.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-16
- Publication Date
- 2024-12-06
AI Technical Summary
During long-term use, the detection sensitivity changes due to the attenuation of biological enzymes and functional membranes, resulting in inaccurate blood glucose detection results, and the performance differences between different sensors lead to large errors after calibration.
By outputting a square wave signal to the implanted detector device, receiving the responding current signal, and generating a calibration curve based on the signal relationship, calibrating and functional verification of the detection device, personalizing the performance differences of different detector devices.
It improves the accuracy of the detection device for the concentration of the substance to be measured, ensures the working stability of the detection device, and reduces detection errors caused by defects.
Smart Images

Figure CN119073976A_ABST
Abstract
Description
Technical Field
[0001] The embodiments of the present application relate to the field of data processing technology, and in particular to a calibration method for an implantable detection device, an implantable detection device, an apparatus, and an electronic device. Background Art
[0002] As an important way to comprehensively manage diabetes, blood glucose testing plays an extremely important role in diabetes diagnosis, diabetes control and diabetes treatment. Long-term continuous dynamic blood glucose testing can effectively reduce or delay the occurrence of diabetes complications and improve the quality of life of patients. The continuous glucose monitoring system can continuously monitor blood glucose for 7 days, 10 days or 14 days. However, due to the biological enzymes and functional membrane layers in the sensors of the continuous glucose monitoring system, electrode passivation, enzyme activity attenuation, enzyme and electron media loss, and functional membrane layer expansion will occur during the long-term monitoring process, resulting in changes in the sensitivity of the sensor to glucose detection, thereby causing inaccurate detection results of the continuous glucose monitoring system.
[0003] Currently, in the process of producing blood glucose detection sensors, manufacturers conduct a large number of tests on sensors with the same production process to obtain an experience curve of how the sensor sensitivity changes over time, and then implant the experience curve into the continuous glucose monitoring system. When the continuous glucose monitoring system is used, the experience curve is called to automatically adjust the sensitivity of the sensor.
[0004] However, there are performance differences between different sensors, and the consistency differences between sensors result in large errors in blood glucose test results after the sensors are calibrated using the empirical curve. Summary of the invention
[0005] In view of this, embodiments of the present application provide a calibration method for an implantable detection device, an implantable detection device, an apparatus, and an electronic device to at least partially solve the above-mentioned problems.
[0006] According to a first aspect of an embodiment of the present application, a calibration method for an implantable detection device is provided, which is applied to a calibration device for an implantable detection device, comprising: outputting a square wave signal to the implantable detection device that has been implanted in a receptor, wherein the implantable detection device is used to detect the concentration of a substance to be detected in the receptor, and the potential of the square wave signal increases in time sequence; receiving a first current signal generated by the implantable detection device in response to the square wave signal; generating a calibration curve based on the correspondence between the first current signal and the square wave signal; and calibrating and / or functionally verifying the implantable detection device based on the calibration curve.
[0007] According to a second aspect of an embodiment of the present application, an implantable detection device is provided, comprising: a first substrate, a first functional film layer, and a first electrode group formed on the first substrate, the first electrode group comprising a first working electrode, a first counter electrode, and a first reference electrode, and the first functional film layer covers the first substrate and the first electrode group.
[0008] According to a third aspect of an embodiment of the present application, an implantable detection device is provided, comprising: a second substrate, a second functional film layer, and a second electrode group formed on the second substrate, the second electrode group comprising a second working electrode, a third working electrode, a second counter electrode, and a second reference electrode, and the second functional film layer covers the second substrate and the second electrode group.
[0009] According to a fourth aspect of an embodiment of the present application, a verification device for an implantable detection device is provided, comprising: an output unit for outputting a square wave signal to the implantable detection device that has been implanted in a receptor, wherein the implantable detection device is used to detect the concentration of a substance to be detected in the receptor, and the potential of the square wave signal increases in time sequence; a receiving unit for receiving a first current signal generated by the implantable detection device in response to the square wave signal; a generating unit for generating a calibration curve according to a correspondence between the first current signal and the square wave signal; and a verification unit for calibrating and / or functionally verifying the implantable detection device according to the calibration curve.
[0010] According to a fifth aspect of an embodiment of the present application, there is provided an electronic device, comprising: a verification device for an implantable detection device as described in the fourth aspect.
[0011] According to the verification method of the implantable detection device provided in the embodiment of the present application, a square wave signal is output to the implantable detection device implanted in the receptor, a first current signal generated by the implantable detection device in response to the square wave signal is received, and a calibration curve is generated according to the correspondence between the first current signal and the square wave signal, thereby the implantable detection device can be calibrated and / or functionally verified according to the calibration curve, the implantable detection device implanted in the receptor can be calibrated, different calibrations can be performed for different implantable detection devices, and the performance differences of different implantable detection devices are taken into account during calibration. Compared with the prior art of calibrating the implantable detection device through the empirical curve, the calibrated implantable detection device can detect the concentration of the substance to be detected more accurately, and the implantable detection device can be functionally verified through the calibration curve, thereby determining the working state of the implantable detection device, preventing large errors in the concentration detection of the substance to be detected due to defects in the implantable detection device, and improving the working stability of the implantable detection device. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the embodiments of the present application. For ordinary technicians in this field, other drawings can also be obtained based on these drawings.
[0013] Figure 1 It is a flow chart of a calibration method of an implantable detection device provided in an embodiment of the present application;
[0014] Figure 2 is a schematic diagram of a square wave signal provided in an embodiment of the present application;
[0015] Figure 3 is a flow chart of a calibration method provided in an embodiment of the present application;
[0016] Figure 4 is a schematic diagram of a reference curve provided in an embodiment of the present application;
[0017] Figure 5 is a schematic diagram of sensitivity attenuation provided in an embodiment of the present application;
[0018] Figure 6 is a schematic diagram of a calibration curve of a hydration process provided in an embodiment of the present application;
[0019] Figure 7 It is a schematic diagram of the corresponding relationship between a square wave signal and a calibration curve provided in an embodiment of the present application;
[0020] Figure 8 is a schematic diagram of an implantable detection device provided in an embodiment of the present application;
[0021] Fig. 9 is a schematic diagram of another implantable detection device provided in an embodiment of the present application;
[0022] Fig.10 It is a schematic diagram of a verification device for an implantable detection device provided in an embodiment of the present application. DETAILED DESCRIPTION
[0023] In order to enable those skilled in the art to better understand the technical solutions in the embodiments of the present application, the technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. All other embodiments obtained by ordinary technicians in this field based on the embodiments in the embodiments of the present application should fall within the scope of protection of the embodiments of the present application.
[0024] The terms used in this application are for the purpose of describing specific embodiments only and are not intended to limit this application. The singular forms of "a", "said" and "the" used in this application and the appended claims are also intended to include plural forms unless the context clearly indicates other meanings. It should also be understood that the term "and / or" used herein refers to and includes any or all possible combinations of one or more associated listed items.
[0025] It should be understood that although the terms first, second, third, etc. may be used in the present application to describe various information, these information should not be limited to these terms. These terms are only used to distinguish the same type of information from each other. For example, without departing from the scope of the present application, the first information may also be referred to as the second information, and similarly, the second information may also be referred to as the first information. Depending on the context, the word "if" as used herein may be interpreted as "at the time of" or "when" or "in response to determining".
[0026] As mentioned above, with the improvement of people's living standards, the incidence of diabetes is getting higher and higher, and blood glucose testing is also receiving more and more attention. As an important way to manage diabetes comprehensively, blood glucose testing plays an extremely important role in diabetes diagnosis, diabetes control and diabetes treatment. Long-term continuous dynamic blood glucose testing can effectively reduce or delay the occurrence of diabetes complications and improve the quality of life of patients. The continuous glucose monitoring system can continuously monitor blood glucose for 7 days, 10 days or 14 days. However, due to the long-term monitoring process of the biological enzymes and functional membrane layers in the sensors of the continuous glucose monitoring system, electrode passivation, enzyme activity attenuation, enzyme and electron media loss and functional membrane layer expansion will occur, resulting in changes in the sensitivity of the sensor to glucose detection, thereby causing inaccurate detection results of the continuous glucose monitoring system. At present, in the process of producing blood glucose detection sensors, manufacturers conduct a large number of tests on sensors with the same production process to obtain the experience curve of the sensor sensitivity changing over time, and then implant the experience curve into the continuous glucose monitoring system. When the continuous glucose monitoring system is used, the experience curve is called to automatically adjust the sensitivity of the sensor. However, there are performance differences between different sensors, and the consistency differences between sensors lead to large errors in the blood glucose detection results after the sensor is calibrated by the experience curve.
[0027] An embodiment of the present application provides a method for calibrating an implantable detection device, which outputs a square wave signal to an implantable detection device that has been implanted in a receptor, receives a first current signal generated by the implantable detection device in response to the square wave signal, and generates a calibration curve according to the correspondence between the first current signal and the square wave signal, thereby calibrating and / or functionally verifying the implantable detection device according to the calibration curve, and can calibrate the implantable detection device that has been implanted in the receptor, and can perform different calibrations for different implantable detection devices, taking into account the performance differences of different implantable detection devices during calibration, and compared with the prior art of calibrating the implantable detection device through an empirical curve, the calibrated implantable detection device can detect the concentration of the substance to be detected more accurately, and the implantable detection device can be functionally verified through the calibration curve, thereby determining the working state of the implantable detection device, and preventing large concentration detection errors of the substance to be detected due to defects in the implantable detection device, thereby improving the working stability of the implantable detection device.
[0028] The following is an example of an embodiment to illustrate the calibration method of the implantable detection device provided by the present application.
[0029] Figure 1 is a flow chart of a calibration method for an implantable detection device provided in an embodiment of the present application. The calibration method for an implantable detection device is applied to a calibration device for an implantable detection device, such as Figure 1 As shown, the verification method of the implantable detection device includes the following steps 101 to 102:
[0030] Step 101: output a square wave signal to an implantable detection device that has been implanted into a recipient.
[0031] The implantable detection device can detect the concentration of the substance to be detected in the receptor. The substance to be detected can be a substance in the receptor body such as blood sugar, blood ketone, uric acid, lactic acid, etc., and output a square wave signal to the implantable detection device that has been implanted in the receptor. The potential of the square wave signal increases in time sequence, that is, the low-level voltage and high-level voltage of the square wave signal increase in each cycle. In one example, Figure 2 is a schematic diagram of a square wave signal provided in an embodiment of the present application, Figure 2 The horizontal axis represents time, and the vertical axis represents voltage value, such as Figure 2 As shown, the low level and high level timing of the square wave signal increase gradually.
[0032] Step 102: Receive a first current signal generated by the implantable detection device in response to the square wave signal.
[0033] A square wave voltage is applied to the implantable detection device. Under the stimulation of the square wave voltage, characteristic substances or groups on the implantable detection device undergo a rapid electrochemical reaction on the working electrode to generate a first current signal.
[0034] Step 103: Generate a calibration curve according to the corresponding relationship between the first current signal and the square wave signal.
[0035] Since the potential of the square wave signal increases sequentially, and since the potential of the square wave signal is different, the first current signal generated by the implantable detection device is different, a calibration curve is generated based on the corresponding relationship between the potential of the square wave signal and the first current signal, and the calibration curve can indicate the corresponding relationship between voltage and current.
[0036] Step 104: calibrate and / or verify the function of the implantable detection device according to the calibration curve.
[0037] The implantable detection device is calibrated according to the calibration curve. For example, the detection sensitivity of the implantable detection device can be adjusted according to the calibration curve, and / or the function of the implantable detection device is verified according to the calibration curve. For example, it is determined according to the calibration curve whether the implantable detection device is damaged, whether it is working normally, whether initialization is completed, etc.
[0038] In an embodiment of the present application, a square wave signal is output to an implantable detection device that has been implanted in a receptor, a first current signal generated by the implantable detection device in response to the square wave signal is received, and a calibration curve is generated according to the correspondence between the first current signal and the square wave signal, thereby the implantable detection device can be calibrated and / or functionally verified according to the calibration curve, the implantable detection device that has been implanted in the receptor can be calibrated, different calibrations can be performed for different implantable detection devices, and performance differences of different implantable detection devices are taken into account during calibration. Compared with the prior art of calibrating the implantable detection device through the empirical curve, the calibrated implantable detection device can detect the concentration of the substance to be measured more accurately, and the implantable detection device can be functionally verified through the calibration curve, thereby determining the working state of the implantable detection device, preventing large errors in the concentration detection of the substance to be measured due to defects in the implantable detection device, and improving the working stability of the implantable detection device.
[0039] Figure 3 is a flow chart of a calibration method provided in an embodiment of the present application, such as Figure 3 As shown, when the implantable detection device is calibrated according to the calibration curve, the following steps 301 to 305 may be performed:
[0040] Step 301: Acquire a first output signal generated by an implantable detection device in response to a detection signal.
[0041] A detection signal is output to the implantable detection device, and the detection signal may be a constant voltage signal. After receiving the detection signal, the implantable detection device detects the concentration of the substance to be detected in the receptor according to the detection signal and generates a first output signal.
[0042] Step 302: Determine the concentration of the substance to be tested according to the first output signal and the first corresponding relationship.
[0043] The first corresponding relationship may indicate the corresponding relationship between the output signal generated by the implantable detection device in response to the detection signal and the concentration of the substance to be detected. It should be understood that the concentration of the substance to be detected is proportional to the first output signal, that is, the higher the concentration of the substance to be detected, the greater the signal intensity of the first output signal. The first corresponding relationship may be a corresponding relationship preset by the manufacturer of the implantable detection device.
[0044] Step 303: Obtain a corresponding reference curve according to the concentration of the substance to be tested.
[0045] According to the measured concentration of the substance to be tested, a reference curve corresponding to the concentration of the substance to be tested is determined. It should be understood that when the voltage is consistent, the higher the concentration of the substance to be tested, the greater the signal intensity of the first output signal. Figure 4 is a schematic diagram of a reference curve provided in an embodiment of the present application, Figure 4 The horizontal axis represents voltage, and the vertical axis represents current, such as Figure 4 As shown, taking the detection of glucose concentration in the blood by an implantable detection device as an example, when glucose exists in the blood, the enzyme in the implantable detection device catalyzes glucose to produce electrons which are transferred to the electron mediator in the implantable detection device. The electron mediator loses electrons on the electrode surface in the implantable detection device, and it is easy to realize redox reaction. Therefore, when the glucose concentration on the electrode surface of the implantable detection device is higher, the more electrons are produced by the biological enzyme layer of the implantable detection device to oxidize glucose, and the electron mediator on the electrode surface is more likely to obtain electrons and be oxidized. Therefore, the voltage corresponding to the peak current of the oxidation reaction of the implantable detection device moves toward 0V as the glucose concentration increases, as shown in FIG. Figure 4 As shown, the concentration of glucose has a significant effect on the voltage corresponding to the redox reaction peak current in the reference curve. As the concentration of glucose continues to increase, the voltage corresponding to the redox reaction peak current in the reference curve gradually shifts toward the positive potential. Since the current magnitude of the redox reaction peak current in the reference curve of the implantable detection device is related to the concentration of the electron mediator on the electrode surface, when the electron mediator on the electrode surface is in a stable or saturated state, it has no significant effect on the current magnitude of the redox reaction peak current in the reference curve. Therefore, the current magnitude of the redox reaction peak current will not be affected by the concentration of glucose. It should be understood that the above is only an example for convenience of explanation and should not impose any limitations on the embodiments of the present application.
[0046] Step 304: Determine a first difference between a voltage corresponding to a peak current of the calibration curve and a voltage corresponding to a peak current of the reference curve.
[0047] Taking glucose in the above example as an example, a square wave signal is output to the implantable detection device implanted in the receptor, and a first current signal generated by the implantable detection device in response to the square wave signal is received. A calibration curve is generated according to the correspondence between the first current signal and the square wave signal, and the voltage corresponding to the peak current in the calibration curve is determined. Assuming that the concentration of glucose is 10mM at this time, the voltage corresponding to the peak current of the reference curve corresponding to the glucose concentration of 10mM is subtracted from the voltage corresponding to the peak current in the calibration curve to determine the first difference between the voltage corresponding to the peak current of the calibration curve and the voltage corresponding to the peak current of the reference curve.
[0048] Step 305: If the first difference is outside the first error range, calibrate the first corresponding relationship according to the calibration curve, or issue a prompt message for calibrating the first corresponding relationship.
[0049] The first error range can be set as needed. When the first difference is outside the first error range, it proves that the implantable detection device has a large deviation in detecting the concentration of the substance to be detected. At this time, the first corresponding relationship is calibrated according to the calibration curve, that is, the corresponding relationship between the output signal of the implantable detection device and the concentration of the substance to be detected is calibrated. In one example, the first corresponding relationship can be calibrated through a calibration curve using a pre-trained calibration model.
[0050] Alternatively, a prompt signal may be sent, the prompt signal may indicate that the implantable detection device needs to be calibrated, and the prompt signal may be used to prompt a manual calibration of the first corresponding relationship.
[0051] In an embodiment of the present application, a first output signal generated by the implantable detection device in response to the detection signal is obtained, the concentration of the substance to be detected is determined based on the first output signal and the first corresponding relationship, and a corresponding reference curve is obtained based on the concentration of the substance to be detected. If the first difference between the voltage corresponding to the peak current of the reference curve and the voltage corresponding to the peak current of the calibration curve is outside the first error range, the first corresponding relationship is calibrated according to the calibration curve. This allows automatic calibration of the implantable detection device when it is detected that the concentration of the substance to be detected deviates greatly from the actual concentration. Since the difference between the voltage corresponding to the peak current of the reference curve and the voltage corresponding to the peak current of the calibration curve is used to automatically detect whether the implantable detection device needs to be calibrated, the implantable detection device can be automatically calibrated in time when the detection deviation of the implantable detection device is large, or a manual calibration can be prompted to be performed manually, so that the implantable detection device can detect the concentration of the substance to be detected more accurately.
[0052] In one possible implementation, when calibrating the implantable detection device according to the calibration curve, a historical calibration curve generated after the last square wave signal was output to the implantable detection device can be obtained to determine the second difference between the peak current of the calibration curve and the peak current of the historical calibration curve. If the second difference is outside the second error range, the implantable detection device is calibrated according to the calibration curve.
[0053] First, the sensitivity change of the implantable detection device is explained by taking glucose as an example of the substance to be detected. In the short period of time during the use of the implantable detection device, such as 12h, 6h or 3h, the sensitivity of the implantable detection device to glucose remains almost unchanged, and the redox peak current of the calibration curve remains unchanged and is not affected by the change in glucose concentration. However, when the implantable detection device has been working for a long time, such as 24h, 48h, or 72h, the loss of the enzyme layer on the implantable detection device causes the enzyme layer activity to decay, and the slow loss of characteristic substances or groups on the electrode causes the electron transfer ability to decrease, which will cause the detection sensitivity of the implantable detection device to glucose to decrease, that is, the signal strength of the current signal output by the implantable detection device at the same glucose concentration is reduced. Figure 5 is a schematic diagram of sensitivity attenuation provided in an embodiment of the present application, Figure 5 The horizontal axis represents voltage, the vertical axis represents current, T (h) represents time, and I (nA) represents current. Figure 5 As shown, the implantable detection device is tested in 10mM glucose buffer for 337h, i.e., a 14-day sensitivity test. At different test times such as 4h, 74h, 171h, 267h, and 337h, the implantable detection device outputs a square wave signal to generate multiple calibration curves, such as Figure 5 As shown, it can be found that the redox peak current of the calibration curve corresponding to different times decreases with the increase of time, from about 2.1uA to 1.5uA, attenuating by 28.57%, indicating that the enzyme layer and the characteristic substances or groups with electrochemical activity on the implantable detection device have been lost to varying degrees. At the same time, due to the loss of the enzyme layer and the characteristic substances or groups with electrochemical activity, the sensitivity of the implantable detection device to glucose will decrease from about 0.14nA / mM to 0.1nA / mM, and the sensitivity will be attenuated by about 28.6%. It can be seen that the change in the redox peak current in the calibration curve of the implantable detection device has a clear corresponding relationship with the change in the sensitivity of the implantable detection device to glucose after long-term operation.
[0054] When calibrating the implantable detection device according to the calibration curve, a historical calibration curve generated after the square wave signal was output to the implantable detection device last time and the received first current signal can be obtained to determine the second difference between the peak current of the calibration curve generated after the square wave signal is output to the implantable detection device this time and the peak current of the historical calibration curve. If the second difference is outside the second error range, it is determined that the sensitivity attenuation of the implantable detection device is large. At this time, the implantable detection device is calibrated according to the calibration curve. Optionally, when calibrating the implantable detection device according to the calibration curve, it can be automatically calibrated through the calibration model according to the calibration curve, or a prompt message can be sent to the human that the first corresponding relationship needs to be manually calibrated.
[0055] Optionally, a square wave signal can be output periodically to the implantable detection device to periodically detect the degree of sensitivity attenuation of the implantable detection device, or a condition for outputting a square wave signal to the implantable detection device can be set, and a square wave signal is output to the implantable detection device when the condition is met. The condition can be set as needed, for example: it can be set to a concentration of the substance to be measured that is greater than a concentration threshold, etc. Taking glucose as an example, when obtaining the calibration curve of the implantable detection device, that is, when outputting a square wave signal to the implantable detection device, it is necessary to select a relatively stable state of blood sugar changes, such as before breakfast, or 3 hours after a meal, etc., to avoid large fluctuations in blood sugar caused by meals or strenuous exercise. Interference with the first current signal, therefore, the blood sugar change range can be set as a condition for outputting a square wave signal to the implantable detection device.
[0056] In an embodiment of the present application, a historical calibration curve generated by the last square wave signal output to the implantable detection device is obtained, and a second difference between the peak current of the calibration curve and the peak current of the historical calibration curve is determined. If the second difference is outside the second error range, the implantable detection device is calibrated according to the calibration curve. In this way, the implantable detection device can be calibrated in time when the sensitivity attenuation of the implantable detection device is large, which can prevent the implantable detection device from having a low accuracy in detecting the concentration of the substance to be measured due to the sensitivity attenuation of the implantable detection device, and can make the implantable detection device detect the concentration of the substance to be measured more accurately.
[0057] In one possible implementation, when a calibration curve is generated for the first time after the implantable detection device is implanted in a recipient, when the function of the implantable detection device is verified based on the calibration curve, if the waveform of the calibration curve conforms to the waveform change law, and the peak current of the calibration curve is within the reference current range, and the voltage corresponding to the peak current is within the reference voltage range, then it is determined that the implantable detection device is functioning normally.
[0058] When the calibration curve is generated for the first time after the implantable detection device is implanted in the recipient for the first time, it can be determined whether the waveform of the calibration curve conforms to the waveform variation law, for example: whether it conforms to the following: Figure 4 and Figure 5 The waveform shown, that is, whether the square wave signal voltage changes from negative to positive, the current changes from large to small and then from small to large, and after reaching the peak value, it decreases symmetrically and then tends to a stable state. It can be determined by judging whether the current magnitude of the peak current of the calibration curve is within the reference current range, and whether the voltage corresponding to the peak current is within the reference voltage range. For example, it can be determined whether the current magnitude of the peak current is within (2.4μA, 2.7μA), and whether the voltage corresponding to the peak current is within (-0.3V, -0.2V), so as to determine whether the function of the implantable detection device is normal.
[0059] It should be noted that when the implantable detection device is initially implanted into the recipient, the current generated by the implantable detection device is affected by the hydration state of the membrane layer, resulting in a large change in the current. In addition, whether the electrode of the implantable detection device is damaged during the implantation process or whether the reference electrode functions normally cannot be determined by the current size. Since the correct calibration curve can only be determined when the reference electrode, working electrode, and counter electrode of the implantable detection device function normally, it is possible to judge whether the implantable detection device functions normally after implantation by judging whether the shape of the calibration curve conforms to the waveform change law, whether the peak current of the calibration curve is within the reference current range, and whether the voltage corresponding to the peak current is within the reference voltage range.
[0060] In an embodiment of the present application, when a calibration curve is generated for the first time after the implantable detection device is first implanted in a receptor, if the waveform of the calibration curve conforms to the waveform change law and the peak current of the calibration curve is within the peak current range, it is determined that the function of the implantable detection device is normal. After the implantable detection device is first implanted in a receptor, the function of the implantable detection device can be verified to determine whether the implantable detection device is damaged, thereby preventing the accuracy of the concentration detection of the substance to be tested from being low due to damage to the implantable detection device, thereby causing adverse effects on the wearer.
[0061] In one possible implementation, when the function of the implantable detection device is verified according to the calibration curve, the kth calibration curve generated after the square wave signal is output to the implantable detection device for the kth time can be obtained, where k is an integer greater than 1, and the first time duration between the time when the implantable detection device is implanted into the recipient and the time when the kth calibration curve is obtained is determined. If the first time duration is less than the time duration threshold, and the voltage corresponding to the peak current in the kth calibration curve is within the voltage range, and the voltage corresponding to the peak current in the 1st to k-1st calibration curves is outside the voltage range, it is determined that the initialization of the implantable detection device is completed, so that a detection signal is output to the implantable detection device after the initialization of the implantable detection device is completed.
[0062] Within a preset time threshold, a square wave signal is output to the implantable detection device multiple times, and the implantable detection device generates multiple calibration curves according to the multiple square wave signals.
[0063] The following describes the initialization process of the implantable detection device using glucose as the substance to be detected. After the implantable detection device is implanted into the receptor, it will undergo a hydration process. The specific hydration process is as follows: the functional membrane layer in the working area of the implantable detection device contacts the tissue fluid, and the water molecules and glucose in the tissue fluid penetrate into the functional membrane layer of the implantable detection device, and an electrochemical reaction occurs. At this time, the membrane layer transforms from a dry membrane to a wet membrane, and the activity of the enzyme layer and the permeability of the functional layer to glucose are unstable. The hydration process generally takes 1 to 2 hours, or even longer. At this time, a square wave signal is output to the implantable detection device, and a calibration curve is generated. The changes in the calibration curve during the hydration process can reflect the hydration state of the implantable detection device. Figure 6 is a schematic diagram of a calibration curve of a hydration process provided in an embodiment of the present application, Figure 6 The horizontal axis represents voltage, and the vertical axis represents current, such as Figure 6 As shown, as the implantable detection device is implanted into the receptor, the hydration process begins, and the voltage corresponding to the redox peak current of the calibration curve corresponding to the implantable detection device at 0h, 0.5h, 1h, 1.5h, 2h, and 3h of hydration gradually moves toward the positive potential. The movement of the voltage corresponding to the redox peak current of the calibration curve is related to the electron transfer rate on the electrode surface. The electron transfer rate on the electrode surface is closely related to the ion environment and mass transfer rate on the electrode surface. The hydration process of the implantable detection device is the process of rebuilding the ion environment on the working electrode surface of the implantable detection device. The stretching and expansion of the functional membrane layer in contact with water causes a change in the mass transfer rate. Therefore, the voltage change corresponding to the redox peak current in the calibration curve on the implantable detection device can reflect the degree of hydration of the implantable detection device. Figure 6 As shown, the calibration curves of the implantable detection device at 2h and 3h overlap, indicating that the hydration process of the implantable detection device is completed after 2h of hydration, the ion environment and mass transfer rate of the electrode surface of the implantable detection device remain stable, and the electrochemical performance of the implantable detection device is in a stable state.
[0064] As can be seen from the above example, when the implantable detection device is functionally verified according to the calibration curve, the kth calibration curve generated after the kth square wave signal is output to the implantable detection device can be obtained. If the voltage corresponding to the peak current of the kth calibration curve is within the voltage range, and the voltage corresponding to the peak current of the 1st calibration curve to the k-1th calibration curve is outside the voltage range, it is determined that the implantable detection device is initialized, that is, hydration is completed, for example: Figure 6In the figure, the calibration curve corresponding to 2h is the kth calibration curve, the calibration curves corresponding to 0h, 0.5h, 1h, and 1.5h are the 1st to k-1th calibration curves, the voltage corresponding to the peak current of the kth calibration curve is within the voltage range (-110mV, 0mV), and the voltage corresponding to the peak current of the 1st to k-1th calibration curves is outside the voltage range (-110mV, 0mV), which proves that the implantable detection device is initialized, that is, hydration is completed. At this time, a detection signal can be output to the implantable detection device to calibrate the implantable detection device or detect the concentration of the substance to be tested through the implantable detection device. It should be noted that the duration threshold is generally greater than the time for the implantable detection device to be hydrated. If the voltage corresponding to the peak current of the calibration curve meets the voltage range requirement within the duration threshold in the first duration, the implantable detection device is initialized.
[0065] In an embodiment of the present application, a kth calibration curve generated after outputting a square wave signal to the implantable detection device for the kth time is obtained. If the first time length between obtaining the kth calibration curve and the time when the implantable detection device is implanted is less than a time length threshold, and the voltage corresponding to the peak current in the kth calibration curve is within the voltage range, and the voltage corresponding to the peak current in the 1st to k-1th calibration curves is outside the voltage range, then it is determined that the initialization of the implantable detection device is completed. Thus, the initialization process of the implantable detection device can be checked, and the implantable detection device can be calibrated in time after the initialization process of the implantable detection device is completed. This can prevent the implantable detection device from being calibrated when the electrochemical state of the implantable detection device is unstable, resulting in an error in the correspondence between the current signal output by the implantable detection device after calibration and the concentration of the substance to be measured, so that the implantable detection device can detect the concentration of the substance to be measured more accurately.
[0066] In one possible implementation, when the function of the implantable detection device is verified according to the calibration curve, if the voltage corresponding to the peak current in the final calibration curve is outside the voltage range, then after calibrating the first corresponding relationship according to the final calibration curve, it is determined that the initialization of the implantable detection device is completed, so as to output a detection signal to the implantable detection device after the initialization of the implantable detection device is completed, wherein the final calibration curve is the last calibration curve obtained within the first time period.
[0067] If the voltage corresponding to the peak current of the last calibration curve obtained within the first time period is outside the voltage range, and the voltages corresponding to the peak currents of all calibration curves obtained within the first time period are all outside the voltage range, then it is determined that the implanted detection device has completed the hydration process, but due to defects in the implanted detection device itself or other reasons, the sensitivity of the implanted detection device is low, that is, the voltage corresponding to the peak current of the calibration curve of the implanted detection device cannot reach the voltage range. At this time, the implanted detection device can be calibrated by the last calibration curve, that is, the last calibration curve obtained, so that the implanted detection device can detect the concentration of the substance to be tested. The calibrated implanted detection device is determined to be initialized, so that the implanted detection device can work normally. It should be noted that the calibration method in any of the above embodiments can be executed to calibrate the implanted detection device according to the last calibration curve, which will not be repeated here.
[0068] In an embodiment of the present application, if the voltage corresponding to the peak current of the last calibration curve obtained within the first time period is outside the voltage range, then after calibrating the first corresponding relationship according to the last calibration curve, it is determined that the initialization of the implantable detection device is completed. This allows the implantable detection device whose sensitivity is reduced due to its own defects or other reasons to normally detect the concentration of the substance to be tested, thereby improving the utilization rate of the implantable detection device.
[0069] In one possible implementation, the implantable detection device includes a first substrate, a first functional film layer and a first electrode group formed on the first substrate, the first electrode group includes a first working electrode, a first counter electrode and a first reference electrode, the first functional film layer covers the first substrate and the first electrode group, and when a square wave signal is output to the implantable detection device that has been implanted in a receptor, the detection signal can be stopped from being output to the first working electrode, and a square wave signal can be output to the first working electrode.
[0070] Since the first working electrode of the implantable detection device with three electrodes receives the detection signal to generate a first output signal to detect the concentration of the substance to be detected, when a square wave signal is sent to the implantable detection device including three electrodes, it is necessary to stop outputting the detection signal to the first working electrode, and send a square wave signal to the first working electrode after stopping outputting the detection signal. Optionally, since the detection signal (constant voltage potential) on the first working electrode will be switched to a square wave signal, an algorithm can be used to eliminate the interference caused by the voltage switching of the first working electrode of the implantable detection device on the stability of the constant voltage potential detection signal.
[0071] In an embodiment of the present application, for an implantable detection device including three electrodes, when a square wave signal is output to the implantable detection device, the output of the detection signal to the first working electrode can be stopped, and a square wave signal can be output to the first working electrode, thereby achieving the output of a square wave signal to the implantable detection device, which can prevent the calibration curve generation process from interfering with the constant voltage potential detection signal.
[0072] In one possible implementation, the implantable detection device includes a second substrate, a second functional film layer and a second electrode group formed on the second substrate, the second electrode group includes a second working electrode, a third working electrode, a second counter electrode and a second reference electrode, the second functional film layer covers the second substrate and the second electrode group, and when a square wave signal is output to the implantable detection device that has been implanted in a receptor, the square wave signal can be output to one of the second working electrode and the third working electrode, wherein the other of the second working electrode and the third working electrode receives the detection signal.
[0073] For an implantable detection device including four electrodes, that is, an implantable detection device including a second working electrode and a third working electrode, a square wave signal can be output to one of the second working electrode and the third working electrode, and a detection signal can be output to the other. Thus, the concentration of the substance to be detected can be detected through one working electrode, and a calibration curve can be generated through the other working electrode. Optionally, the detection signal can be output to the second working electrode and the third working electrode at the same time, and when it is necessary to generate a calibration curve, the square wave signal is output after the detection signal is stopped to one of the second working electrode and the third working electrode. Thus, when it is not necessary to generate a calibration curve, the concentration of the substance to be detected can be detected through the two working electrodes, thereby improving the detection accuracy.
[0074] In an embodiment of the present application, for an implantable detection device including four electrodes, when a square wave signal is output to the implantable detection device, a square wave signal can be output to one of the second working electrode and the third working electrode, and a detection signal can be output to the other of the second working electrode and the third working electrode, thereby achieving the output of a square wave signal to the implantable detection device, and the concentration of the substance to be detected can be detected while generating a calibration curve. Moreover, since it is necessary to determine a reference curve by the concentration of the substance to be detected when calibrating the implantable detection device, the simultaneous generation of the calibration curve and the detection of the concentration of the substance to be detected can determine the concentration of the substance to be detected while generating the calibration curve. Compared with the three-electrode solution in the above embodiment that detects the concentration first and then generates the calibration curve, the calibration process can be made more accurate. At the same time, the constant voltage potential detection signal and the square wave calibration signal are obtained on different working electrodes, which can avoid signal interference between each other.
[0075] In a possible implementation, the frequency of the square wave signal ranges from [10 Hz to 10 kHz]; the period increment of the square wave signal ranges from (0, 10 mV]; and the signal amplitude of the square wave signal ranges from (0, 50 mV].
[0076] Figure 7 is a schematic diagram of the corresponding relationship between a square wave signal and a calibration curve provided in an embodiment of the present application, Figure 7 The horizontal axis represents voltage, and the vertical axis represents current, such as Figure 7 As shown in FIG. 1 , the peak current of the calibration curve formed at different frequencies of the square wave signal is different. The higher the frequency of the square wave signal, the greater the peak current generated. Figure 7 The current unit of the peak current shown is in the microampere level, which is greater than the first output signal (about 0.5-100 nanoamperes) output by the current implantable detection device, so the calibration curve has good recognition.
[0077] In the embodiment of the present application, the frequency range of the square wave signal is [10Hz-10KHz]; the range of the period increment of the square wave signal is (0,10mV], and the range of the signal amplitude of the square wave signal is (0,50mV], thereby allowing the square wave signal to be set as needed, and outputting a square wave signal with increasing potential timing to the implantable detection device.
[0078] Figure 8 is a schematic diagram of an implantable detection device provided in an embodiment of the present application, such as Figure 8 As shown, the implantable detection device includes: a first substrate 801, a first functional film layer 807 and a first electrode group formed on the first substrate 801, the first electrode group includes a first working electrode 803, a first counter electrode 804 and a first reference electrode 802, and the first functional film layer 807 covers the first substrate 801 and the first electrode group.
[0079] The first substrate 801 may be a flexible substrate, and a plurality of electrodes are prepared on a single side of the first substrate 801 by screen printing, inkjet printing or other techniques to form an independent electrochemical three-electrode system, wherein the first working electrode 803, the first counter electrode 804, and the first reference electrode 802 constitute a first electrode group formed on the first substrate 801. In one example, Figure 8As shown, the characteristic substance or group is located in the film layer 805 above the first working electrode 803. In another example, the characteristic substance or group can be located inside the first working electrode 803, for example: the material of the first working electrode 803. Optionally, the enzyme layer 806 can be located above the film layer 805, or the enzyme and the characteristic substance or group can be mixed into one layer. The main function of the characteristic substance or group is to serve as an electron transporter for the enzyme layer 806, and transfer the electrons generated by the reaction of the enzyme layer 806 with the substance to be tested to the first working electrode 803. The first functional film layer 807 with the transmission of the substance to be tested and biocompatibility covers the entire three-electrode system.
[0080] In an embodiment of the present application, the implantable detection device includes: a first substrate 801, a first electrode group and a first functional film layer 807 formed on the first substrate 801, the first electrode group includes a first working electrode 803, a first counter electrode 804 and a first reference electrode 802, and the first functional film layer 807 covers the first substrate 801 and the first electrode group, thereby the concentration of the substance to be detected can be detected by the implantable detection device.
[0081] Fig. 9 is a schematic diagram of another implantable detection device provided in an embodiment of the present application, such as Fig. 9 As shown, the implantable detection device includes a second substrate 901, a second functional film layer 907 and a second electrode group formed on the second substrate 901, the second electrode group includes a second working electrode 9031, a third working electrode 9032, a second pair of electrodes 904 and a second reference electrode 902, and the second functional film layer 907 covers the second substrate 901 and the second electrode group.
[0082] The second substrate 901 may be a flexible substrate, and a plurality of electrodes are prepared on a single side of the second substrate 901 by screen printing, inkjet printing or other techniques to form an independent electrochemical four-electrode system, wherein the second working electrode 9031, the third working electrode 9032, the second counter electrode 904, and the second reference electrode 902 constitute a first electrode group formed on the first substrate. In one example, Fig. 9As shown, the characteristic substance or group is located in the film layer 9051 above the second working electrode 9031 and the film layer 9052 above the third working electrode 9032. In another example, the characteristic substance or group can be located inside the second working electrode 9031 and the third working electrode 9032, for example: the working electrode material. Optionally, the enzyme layer 9061 can be located in the film layer 9051 and the enzyme layer 9062 can be located above the film layer 9052. The enzyme and the characteristic substance or group can also be mixed into one layer. The main function of the characteristic substance or group is to serve as an electron transfer agent for the enzyme layer 9061 and the enzyme layer 9062, and transfer the electrons generated by the reaction of the enzyme layer with the substance to be tested to the working electrode. The second functional film layer 907907 with the transmission of the substance to be tested and biocompatibility covers the entire four-electrode system.
[0083] In an embodiment of the present application, the implantable detection device includes a second substrate 901, a second functional film layer 907 and a second electrode group formed on the second substrate 901, the second electrode group includes a second working electrode 9031, a third working electrode 9032, a second pair of electrodes 904 and a second reference electrode 902, and the second functional film layer 907 covers the second substrate 901 and the second electrode group, so that the concentration of the substance to be measured can be detected simultaneously by two working electrodes, thereby improving the detection accuracy of the concentration of the substance to be measured.
[0084] It should be noted that the calibration method for the three-electrode implantable detection device and the four-electrode implantable detection device in the above embodiments can refer to the method performed in any of the above embodiments, and will not be repeated here.
[0085] Fig.10 is a schematic diagram of a verification device for an implantable detection device provided in an embodiment of the present application, such as Fig.10 As shown, the device 1000 includes: an output unit 1001, used to output a square wave signal to an implantable detection device that has been implanted in a receptor, wherein the implantable detection device is used to detect the concentration of a substance to be detected in the receptor, and the potential of the square wave signal increases in sequence; a receiving unit 1002, used to receive a first current signal generated by the implantable detection device in response to the square wave signal; a generating unit 1003, used to generate a calibration curve according to the correspondence between the first current signal and the square wave signal; and a verification unit 1004, used to calibrate and / or verify the function of the implantable detection device according to the calibration curve.
[0086] In an embodiment of the present application, the output unit 1001 can be used to execute step 101 in the above method embodiment, the receiving unit 1002 can be used to execute step 102 in the above method embodiment, the generating unit 1003 can be used to execute step 103 in the above method embodiment, and the verification unit 1004 can be used to execute step 105 in the above method embodiment.
[0087] In one possible implementation, the verification unit 1004 can also be used to obtain a first output signal generated by the implantable detection device in response to the detection signal; determine the concentration of the substance to be detected based on the first output signal and the first correspondence, wherein the first correspondence is used to indicate the correspondence between the output signal generated by the implantable detection device in response to the detection signal and the concentration of the substance to be detected; obtain a corresponding reference curve based on the concentration of the substance to be detected; determine a first difference between the voltage corresponding to the peak current of the calibration curve and the voltage corresponding to the peak current of the reference curve; if the first difference is outside the first error range, calibrate the first correspondence according to the calibration curve, or issue a prompt message to calibrate the first correspondence.
[0088] In one possible implementation, the verification unit 1004 can also be used to obtain a historical calibration curve generated after the last square wave signal was output to the implantable detection device; determine a second difference between the peak current of the calibration curve and the peak current of the historical calibration curve; if the second difference is outside the second error range, calibrate the implantable detection device according to the calibration curve.
[0089] In one possible implementation, the verification unit 1004 can also be used to generate a calibration curve for the first time after the implantable detection device is implanted in a recipient. If the waveform of the calibration curve conforms to the waveform change law, and the peak current is within the reference current range, and the voltage corresponding to the peak current is within the reference voltage range, then it is determined that the implantable detection device is functioning normally.
[0090] In one possible implementation, the verification unit 1004 can also be used to obtain the kth calibration curve generated after the square wave signal is output to the implantable detection device for the kth time, where k is an integer greater than 1; determine the first time duration between the time when the implantable detection device is implanted into the recipient and the time when the kth calibration curve is obtained; if the first time duration is less than the time duration threshold, and the voltage corresponding to the peak current in the kth calibration curve is within the voltage range, and the voltage corresponding to the peak current in the 1st to k-1st calibration curves is outside the voltage range, then it is determined that the initialization of the implantable detection device is completed, so as to output a detection signal to the implantable detection device after the initialization of the implantable detection device is completed.
[0091] In one possible implementation, the verification unit 1004 can also be used to determine that the initialization of the implantable detection device is completed after calibrating the first corresponding relationship according to the final calibration curve if the voltage corresponding to the peak current in the final calibration curve is outside the voltage range, so as to output a detection signal to the implantable detection device after the initialization of the implantable detection device is completed, wherein the final calibration curve is the last calibration curve obtained within the first time period.
[0092] In one possible implementation, the implantable detection device includes: a first substrate, a first functional film layer and a first electrode group formed on the first substrate, the first electrode group includes a first working electrode, a first counter electrode and a first reference electrode, and the first functional film layer covers the first substrate and the first electrode group; the output unit 1001 can also be used to stop outputting the detection signal to the first working electrode and output a square wave signal to the first working electrode.
[0093] In one possible implementation, the implantable detection device includes: a second substrate, a second functional film layer and a second electrode group formed on the second substrate, the second electrode group includes a second working electrode, a third working electrode, a second counter electrode and a second reference electrode, and the second functional film layer covers the second substrate and the second electrode group; the output unit 1001 can also be used to output a square wave signal to one of the second working electrode and the third working electrode, wherein the other of the second working electrode and the third working electrode receives the detection signal.
[0094] In a possible implementation, the frequency of the square wave signal ranges from [10 Hz to 10 kHz]; the period increment of the square wave signal ranges from (0, 10 mV]; and the signal amplitude of the square wave signal ranges from (0, 50 mV].
[0095] An embodiment of the present application further provides an electronic device, which includes the verification device 1000 for an implantable detection device in the above embodiment. The verification device 1000 for an implantable detection device can execute the verification method for an implantable detection device in any of the above embodiments.
[0096] It should be pointed out that, according to the needs of implementation, the various components / steps described in the embodiments of the present application can be split into more components / steps, or two or more components / steps or partial operations of components / steps can be combined into new components / steps to achieve the purpose of the embodiments of the present application.
[0097] The above-mentioned method according to the embodiment of the present application can be implemented in hardware, firmware, or implemented as software or computer code that can be stored in a recording medium (such as CD ROM, RAM, floppy disk, hard disk or magneto-optical disk), or implemented as a computer code that is originally stored in a remote recording medium or a non-temporary machine-readable medium downloaded through a network and will be stored in a local recording medium, so that the method described here can be stored in such software processing on a recording medium using a general-purpose computer, a special-purpose processor or programmable or special-purpose hardware (such as ASIC or FPGA). It can be understood that a computer, a processor, a microprocessor controller or programmable hardware includes a storage component (for example, RAM, ROM, flash memory, etc.) that can store or receive software or computer code, and when the software or computer code is accessed and executed by a computer, a processor or hardware, the verification method of the implantable detection device described here is realized. In addition, when a general-purpose computer accesses a code for realizing the verification method of the implantable detection device shown here, the execution of the code converts the general-purpose computer into a special-purpose computer for executing the verification method of the implantable detection device shown here.
[0098] Those of ordinary skill in the art will appreciate that the units and method steps of each example described in conjunction with the embodiments disclosed herein can be implemented in electronic hardware, or a combination of computer software and electronic hardware. Whether these functions are performed in hardware or software depends on the specific application and design constraints of the technical solution. Professional and technical personnel can use different methods to implement the described functions for each specific application, but such implementation should not be considered to be beyond the scope of the embodiments of the present application.
[0099] The above implementation methods are only used to illustrate the embodiments of the present application, and are not limitations on the embodiments of the present application. Ordinary technicians in the relevant technical field can make various changes and modifications without departing from the spirit and scope of the embodiments of the present application. Therefore, all equivalent technical solutions also belong to the scope of the embodiments of the present application. The scope of patent protection of the embodiments of the present application should be limited by the claims.
Claims
1. A method for calibrating an implantable detection device, applied to a calibration device for an implantable detection device, characterized in that: include: Outputting a square wave signal to an implantable detection device that has been implanted in a receptor, wherein the implantable detection device is used to detect the concentration of a substance to be detected in the receptor, and the potential of the square wave signal increases sequentially; receiving a first current signal generated by the implantable detection device in response to the square wave signal; generating a calibration curve according to a corresponding relationship between the first current signal and the square wave signal; The implantable detection device is calibrated and / or functionally verified according to the calibration curve.
2. The method according to claim 1, characterized in that The step of calibrating the implantable detection device according to the calibration curve comprises: Acquiring a first output signal generated by the implantable detection device in response to a detection signal; Determining the concentration of the substance to be detected according to the first output signal and a first corresponding relationship, wherein the first corresponding relationship is used to indicate the corresponding relationship between the output signal generated by the implantable detection device in response to the detection signal and the concentration of the substance to be detected; According to the concentration of the substance to be tested, obtaining a corresponding reference curve; Determine a first difference between a voltage corresponding to a peak current of the calibration curve and a voltage corresponding to a peak current of the reference curve; If the first difference is outside the first error range, the first corresponding relationship is calibrated according to the calibration curve, or a prompt message for calibrating the first corresponding relationship is issued.
3. The method according to claim 1, characterized in that The step of calibrating the implantable detection device according to the calibration curve comprises: Acquiring a historical calibration curve generated after the square wave signal was output to the implantable detection device last time; determining a second difference between a peak current of the calibration curve and a peak current of the historical calibration curve; If the second difference is outside a second error range, the implantable detection device is calibrated according to the calibration curve.
4. The method according to claim 1, characterized in that: When the calibration curve is generated for the first time after the implantable detection device is implanted in the recipient, the function verification of the implantable detection device according to the calibration curve includes: If the waveform of the calibration curve complies with the waveform variation rule, and the peak current of the calibration curve is within the reference current range, and the voltage corresponding to the peak current is within the reference voltage range, it is determined that the implantable detection device functions normally.
5. The method according to claim 2, characterized in that: The function verification of the implantable detection device according to the calibration curve includes: Obtaining a kth calibration curve generated after outputting a square wave signal to the implantable detection device for the kth time, wherein k is an integer greater than 1; Determining a first time duration between the time when the implantable detection device is implanted into the receptor and the time when the kth calibration curve is acquired; If the first time duration is less than the time duration threshold, and the voltage corresponding to the peak current in the kth calibration curve is within the voltage range, and the voltage corresponding to the peak current in the 1st to k-1th calibration curves is outside the voltage range, then it is determined that the initialization of the implantable detection device is completed, so as to output the detection signal to the implantable detection device after the initialization of the implantable detection device is completed.
6. The method according to claim 5, characterized in that The function verification of the implantable detection device according to the calibration curve includes: If the voltage corresponding to the peak current in the final calibration curve is outside the voltage range, after calibrating the first corresponding relationship according to the final calibration curve, it is determined that the initialization of the implantable detection device is completed, so as to output the detection signal to the implantable detection device after the initialization of the implantable detection device is completed, wherein the final calibration curve is the last calibration curve obtained within the first time length.
7. The method according to claim 2, characterized in that The implantable detection device comprises: a first substrate, a first functional film layer and a first electrode group formed on the first substrate, the first electrode group comprises a first working electrode, a first counter electrode and a first reference electrode, and the first functional film layer covers the first substrate and the first electrode group; The step of outputting a square wave signal to an implantable detection device implanted in a recipient comprises: The detection signal is stopped from being output to the first working electrode, and the square wave signal is output to the first working electrode.
8. The method according to claim 2, characterized in that: The implantable detection device comprises: a second substrate, a second functional film layer and a second electrode group formed on the second substrate, the second electrode group comprises a second working electrode, a third working electrode, a second counter electrode and a second reference electrode, and the second functional film layer covers the second substrate and the second electrode group; The step of outputting a square wave signal to an implantable detection device implanted in a recipient comprises: The square wave signal is output to one of the second working electrode and the third working electrode, wherein the other of the second working electrode and the third working electrode receives the detection signal.
9. The method according to any one of claims 1 to 8, characterized in that: The frequency range of the square wave signal is [10 Hz-10 KHz]; the period increment range of the square wave signal is (0, 10 mV], and the signal amplitude range of the square wave signal is (0, 50 mV].
10. An implantable detection device, characterized in that: include: A first substrate, a first functional film layer and a first electrode group formed on the first substrate, the first electrode group includes a first working electrode, a first counter electrode and a first reference electrode, and the first functional film layer covers the first substrate and the first electrode group.
11. An implantable detection device, characterized in that: include: A second substrate, a second functional film layer and a second electrode group formed on the second substrate, the second electrode group includes a second working electrode, a third working electrode, a second counter electrode and a second reference electrode, and the second functional film layer covers the second substrate and the second electrode group.
12. A verification device for an implantable detection device, characterized in that: include: An output unit, used to output a square wave signal to an implantable detection device that has been implanted in a receptor, wherein the implantable detection device is used to detect the concentration of a substance to be detected in the receptor, and the potential of the square wave signal increases sequentially; a receiving unit, configured to receive a first current signal generated by the implantable detection device in response to the square wave signal; A generating unit, configured to generate a calibration curve according to a corresponding relationship between the first current signal and the square wave signal; A verification unit is used to calibrate and / or verify the function of the implantable detection device according to the calibration curve.
13. An electronic device, characterized in that: include: A calibration device for an implantable detection device as claimed in claim 12.
Citation Information
Patent Citations
Metering display device
CN103163199A
Methods and systems for observing sensor parameters
US20100169035A1
Electrochemical sensors
US20120187000A1
Methods and systems for optimizing sensor function by the application of voltage
US20140135605A1
In-body sensor health diagnostics using VSET based methods
US20200000381A1
